C12Y 304/1701
Carboxypeptidase e
Official title: Carboxypeptidase E (3.4.17.10)
C12Y304/1701 (Carboxypeptidase e) appears on 0 US grants and 2 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 2
- Assignees
- 2
- Inventors
- 3
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
No granted patents in this class yet.
- Use of carboxypeptidase e/neurotrophic factor-alpha1 to treat neurodegenerative disease16 Jul 2026US 2026/0199441 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Methods of producing human analog insulins and derivatives thereof in a mammalian cell29 May 2025US 2025/0171517 A1Ice Bear Therapeutics SPC
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.